摘要
目的：探讨结核性包裹性胸腔积液胸腔内分别注入尿激酶或糜蛋白酶的治疗作用。方法：抗结核治疗下，治疗组胸腔内注射尿激酶10万U＋0．9％NaCl溶液10ml／次，对照组胸腔内注射糜蛋白酶4000U＋0．9％NaCl溶液10ml／次。结果：治疗组与对照组总有效率差异有统计学意义（X^2=4．706，P〈0．05）。结论：尿激酶治疗结核性胸腔积液疗效好，建议推广。
Objective To study the clinical effect of urokinase and chymotrypsin injection into thoracic cavity to treat tuberculous encapsulated hydrothorax. Method Total 60 cases of tuberculous encapsulated pleurisy were divided randomly into two groups. All cases had routine therapy. In 30 cases of the treatment group,was extracted out the pleural effusion,then 100 000 U urokinase was injected into thoracic cavity. In 30 cases of the control group, was extracted out the pleural effusion, then 4 000U chymotrypsin was injected into thoracic cavity. Results Compared to the control group, the treatment group drained more pleured fluid （X2 = 4. 706, P 〈 0.05 ）, and pulmonary function was improved. Conclusion There is significant curative effect with urokinase injection into thoracic cavity to treat tuberculous encapsul ated hydrothorax.
出处
《吉林医学》
CAS
2010年第25期4255-4256,共2页
Jilin Medical Journal
关键词
尿激酶
糜蛋白酶
包裹胸腔积液
Urokinase
Chymotrypsin
Tuberculous encapsulated hydrothorax
